Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis

Journal of Proteomics

Volumn 71, Issue 2, 2008, Pages 168-175

  Dowling, Paul ^a   Wormald, Robert ^b   Meleady, Paula ^a   Henry, Michael ^a   Curran, Aongus ^b   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

Author keywords

Biomarker; DIGE; HNSCC; Proteins; Saliva

Indexed keywords

CALGRANULIN B; COFILIN 1; DYE; FIBRIN; IMMUNOGLOBULIN HEAVY CHAIN; PREALBUMIN; PROTEIN; TRANSFERRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SALIVA ANALYSIS; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; PROTEOME; PROTEOMICS; SALIVA; TUMOR MARKERS, BIOLOGICAL;

EID: 46249122635     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2008.04.004     Document Type: Article

References (34)

1. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
2. Decker J., and Goldstein J.C. Risk factors in head and neck cancer. N Engl J Med 306 (1982) 1151-1155
3. Diamandis E. Point: Proteomic patterns in biological fluids: Do they represent the future of cancer diagnostics?. Clin Chem 49 (2003) 1272-1275
4. Kaufman E., and Lamster I.B. The diagnostic applications of saliva-a review. Crit Rev Oral Biol Med 13 (2002) 197-212
5. Tabak L.A. A revolution in biomedical assessment: The development of salivary diagnostics. J Dent Educ 65 (2001) 1335-1339
6. Hu S., Yen Y., Ann D., and Wong D.T. Implications of salivary proteomics in drug discovery and development: A focus on cancer drug discovery. Drug Discov Today 12 (2007) 911-916
7. Dowling P., O'Driscoll L., Meleady P., Henry M., Roy S., Ballot J., et al. 2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins. Electrophoresis 28 (2007) 4302-4310
8. Helmerhorst E.J., and Oppenheim F.G. Saliva: A dynamic proteome. J Dent Res 86 (2007) 680-693
9. Unlü M., Morgan M.E., and Minden J.S. Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 18 (1997) 2071-2077
10. Alban A., David S.O., Bjorkesten L., Andersson C., Sloge E., Lewis S., et al. A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3 (2003) 36-44
11. Tavassoli M., Brunel N., Maher R., Johnson N.W., and Soussi T. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int J Cancer 78 (1998) 390-401
12. Mizukawa N., Sugiyama K., Fukunaga J., Ueno T., Mishima K., Takagi S., et al. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res 18 (1998) 4645-4649
13. Franzmann E.J., Reategui E.P., Carraway K.L., Hamilton K.L., Weed D.T., and Goodwin W.J. Salivary soluble CD44: A potential molecular marker for head and neck cancer. Cancer Epidemiol Biomark Prev 14 (2005) 735-739
14. St John M.A., Li Y., Zhou X., Denny P., Ho C.M., Montemagno C., et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130 (2004) 929-935
15. Streckfus C., Bigler L., Dellinger T., Dai X., Kingman A., and Thigpen J.T. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res 6 (2000) 2363-2370
16. Chen D.X., Schwartz P.E., and Li F.Q. Saliva and serum CA 125 assays for detecting malignant ovarian tumors. Obstet Gynecol 75 (1990) 701-704
17. Yong H.Y., and Moon A. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch Pharm Res 30 (2007) 75-81
18. Stulík J., Osterreicher J., Koupilová K., Knízek, Macela A., Bures J., et al. The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass. Electrophoresis 20 (1999) 1047-1054
19. Sewell D.A., Yuan C.X., and Robertson E. Proteomic signatures in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 69 (2007) 77-84
20. Melle C., Ernst G., Schimmel B., Bleul A., Koscielny S., Wiesner A., et al. A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res 64 (2004) 4099-4104
21. Driemel O., Murzik U., Escher N., Melle C., Bleul A., Dahse R., et al. Protein profiling of oral brush biopsies: S100A8 and S100A9 can differentiate between normal, premalignant, and tumor cells. Proteomics Clin Appl 1 (2007) 486-493
22. Ohshiro K., Rosenthal D.I., Koomen J.M., Streckfus C.F., Chambers M., Kobayashi R., et al. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int J Oncol 30 (2007) 743-749
23. Zacharski L.R., Costantini V., Wojtukiewicz M.Z., Memoli V.A., and Kudryk B.J. Anticoagulants as cancer therapy. Semin Oncol 17 (1990) 217-227
24. Dvorak H.F. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am J Pathol 162 (2003) 1747-1757
25. Zacharski L.R., Memoli V.A., and Rousseau S.M. Cancer-coagulation interaction in situ in renal cell carcinoma. Blood 68 (1986) 394-399
26. Zacharski L.R., Memoli V.A., Rousseau S.M., and Kisiel W. Coagulation-cancer interaction in situ in small cell carcinoma of the lung. Cancer 60 (1987) 2675-2681
27. Zacharski L.R., Memoli V.A., and Rousseau S.M. Thrombin-specific sites of fibrinogen in small cell carcinoma of the lung. Cancer 62 (1988) 299-302
28. Zacharski L.R., Memoli V.A., Ornstein D.L., Rousseau S.M., Kisiel W., and Kudryk B.J. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J Natl Cancer Inst 85 (1993) 1225-1230
29. Wojtukiewicz M.Z., Zacharski L.R., Memoli V.A., Kisiel W., Kudryk B.J., Rousseau S.M., et al. Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung. Cancer 65 (1990) 481-485
30. Wojtukiewicz M.Z., Zacharski L.R., Memoli V.A., Kisiel W., Kudryk B.J., Rousseau S.M., et al. Fibrinogen-fibrin transformation in situ in renal cell carcinoma. Anticancer Res 10 (1990) 579-582
31. Wojtukiewicz M.Z., Zacharski L.R., Memoli V.A., Kisiel W., Kudryk B.J., Rousseau S.M., et al. Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ. Am J Clin Pathol 93 (1990) 516-521
32. Zhang Z., Bast Jr. R.C., Yu Y., Li J., Sokoll L.J., Rai A.J., et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 64 (2004) 5882-5890
33. Turhani D., Krapfenbauer K., Thurnher D., Langen H., and Fountoulakis M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27 (2006) 1417-1423
34. Listgarten J., and Emili A. Practical proteomic biomarker discovery: Taking a step back to leap forward. Drug Discov Today 10 (2005) 1697-1702